364 related articles for article (PubMed ID: 21483013)
1. Pathogenesis of non-Hodgkin's lymphoma.
Nogai H; Dörken B; Lenz G
J Clin Oncol; 2011 May; 29(14):1803-11. PubMed ID: 21483013
[TBL] [Abstract][Full Text] [Related]
2. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
[TBL] [Abstract][Full Text] [Related]
3. Molecular biology and genetics of lymphomas.
Hartmann EM; Ott G; Rosenwald A
Hematol Oncol Clin North Am; 2008 Oct; 22(5):807-23, vii. PubMed ID: 18954738
[TBL] [Abstract][Full Text] [Related]
4. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
Dreyling MH; Roulston D; Bohlander SK; Vardiman J; Olopade OI
Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637
[TBL] [Abstract][Full Text] [Related]
5. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.
Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA
Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma.
Ong ST; Le Beau MM
Semin Oncol; 1998 Aug; 25(4):447-60. PubMed ID: 9728595
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
Jazirehi AR; Bonavida B
Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036
[TBL] [Abstract][Full Text] [Related]
8. In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).
Aya-Bonilla C; Camilleri E; Haupt LM; Lea R; Gandhi MK; Griffiths LR
BMC Genomics; 2014 May; 15(1):390. PubMed ID: 24885312
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 17 numerical abnormalities in 55 patients with non-Hodgkin's lymphoma: a fluorescence in situ hybridization study.
Jendiroba D; Younes A; Katz R; Hill D; Cabanillas F; Andreeff M
Leukemia; 1995 Jul; 9(7):1144-6. PubMed ID: 7630187
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of AIDS-associated non-Hodgkin's lymphoma.
Shiramizu B; McGrath MS
Hematol Oncol Clin North Am; 1991 Apr; 5(2):323-30. PubMed ID: 2022596
[TBL] [Abstract][Full Text] [Related]
11. Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.
Thomázy VA; Luthra R; Uthman MO; Davies PJ; Medeiros LJ
J Mol Diagn; 2002 Nov; 4(4):201-8. PubMed ID: 12411587
[TBL] [Abstract][Full Text] [Related]
12. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
13. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
15. Histogenesis and pathogenesis of follicular small cleaved cell lymphoma (FSCCL), diffuse small cleaved cell lymphoma (DSCCL) and intermediate lymphocytic lymphoma/lymphocytic lymphoma of intermediate differentiation (ILL/IDL).
Abe M; Wakasa H
Fukushima J Med Sci; 1994 Dec; 40(2):85-101. PubMed ID: 7642169
[TBL] [Abstract][Full Text] [Related]
16. [Lymphoma genesis in the context of HIV infection].
Besson C; Raphaël M
Ann Med Interne (Paris); 2003 Dec; 154(8):523-8. PubMed ID: 15037828
[TBL] [Abstract][Full Text] [Related]
17. Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Wiernik PH; Lossos IS; Tuscano JM; Justice G; Vose JM; Cole CE; Lam W; McBride K; Wride K; Pietronigro D; Takeshita K; Ervin-Haynes A; Zeldis JB; Habermann TM
J Clin Oncol; 2008 Oct; 26(30):4952-7. PubMed ID: 18606983
[TBL] [Abstract][Full Text] [Related]
18. Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections.
Haralambieva E; Kleiverda K; Mason DY; Schuuring E; Kluin PM
J Pathol; 2002 Oct; 198(2):163-70. PubMed ID: 12237875
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
20. The relationship between Hodgkin's disease and non-Hodgkin's lymphoma.
Harris NL
Semin Diagn Pathol; 1992 Nov; 9(4):304-10. PubMed ID: 1480853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]